Expand Energy Corporation Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Expand Energy Corporation Common Stock trades at $91.6 (market cap $21.38B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Expand Energy Corporation Common Stock is far larger — about 10× NeoGenomics Inc. Common Stock's market cap, and Expand Energy Corporation Common Stock pays a 2.49% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expand Energy Corporation Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| EXE | NEO | |
|---|---|---|
Market Cap | $21.38B | $2.14B |
Volume | 3,544,570 | 2,228,400 |
Sector | Energy | Health |
52-Week High | $122.89 | $19.91 |
52-Week Low | $84.09 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $24.45B | $2.44B |
Dividend Yield | 2.49% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Expand Energy Corporation is a US natural gas producer formed from the 2024 merger of Chesapeake Energy and Southwestern Energy, developing gas assets concentrated in the Appalachia and Haynesville basins.
Read more on EXE →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →